Mahsa Borjzadehgashtaseb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mahsa Borjzadehgashtaseb has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Salma Nozhat
Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran
3 shared publicationsAhmad Ali Amirghofran
Department of Cardiac Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
2 shared publications- Alireza Arzhangzadeh
Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran
2 shared publications Davar Aledavood
Department of Cardiology, Shiraz University of Medical Sciences , Shiraz 7134814336
2 shared publications- Seyed Alireza Mirhosseini
Cardiovascular Research Center, School of Medicine Shiraz University of Medical Sciences Shiraz Iran
2 shared publications - Soorena Khorshidi
Department of Cardiology, School of Medicine Shiraz University of Medical Sciences Shiraz Iran
2 shared publications
Latest Publications
- Open Access
- 19 August 2026
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (5) , e70319
Efficacy of Telmisartan in MASLD / NAFLD : A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Background: Activation of the renin‐angiotensin‐aldosterone system contributes to hepatic inflammation in metabolic dysfunction‐associated steatotic liver disease (MASLD). Telmisartan, an angiotensin II receptor blocker with partial PPAR‐γ agonistic activity, has been hypothesized to confer metabolic benefits; however, current clinical evidence has not consistently demonstrated such effects. Aim: This systematic review and meta‐analysis evaluated the efficacy of telmisartan on metabolic, biochemical, and histological outcomes in MASLD. Methods: Electronic databases (PubMed, Embase, Web of Science, Scopus) were searched through 2026 for randomized controlled trials (RCTs) investigating telmisartan in adults with MASLD. Risk of bias was assessed using the RoB2 tool. Random‐effects meta‐analyses calculated pooled mean differences (MDs) with 95% confidence intervals (CIs). Results: Six RCTs comprising 258 participants (126 telmisartan, 132 controls) met the inclusion criteria. Telmisartan treatment was associated with a modest reduction in fasting blood sugar compared with controls (MD = −2.78 mg/dL; 95% CI −5.17 to −0.39; p = 0.023); however, this finding was accompanied by substantial heterogeneity (I 2 = 91.8%) and should therefore be interpreted cautiously. No significant changes were observed for body mass index, waist circumference, HOMA‐IR, lipid profiles, ALT, or AST. Conversely, gamma‐glutamyl transferase (GGT) levels showed a modest but significant increase with telmisartan (MD = 5.40 U/L; 95% CI 0.51 to 10.29; p = 0.031). Histological analyses revealed a non‐significant trend toward fibrosis stage improvement (MD = −0.28; 95% CI −0.57 to 0.01; p = 0.060), with no significant improvements seen in the overall NAFLD activity score, steatosis, ballooning, or lobular inflammation. Most included trials carried a low overall risk of bias. Conclusion: Current evidence does not demonstrate consistent metabolic, biochemical, or histological benefits of telmisartan in MASLD. Although a modest reduction in fasting blood glucose was observed, substantial between‐study heterogeneity and the modest effect size limit confidence in this finding.
- 19 August 2026
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (5) , e70319
Open AccessEfficacy of Telmisartan in MASLD / NAFLD : A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Background: Activation of the renin‐angiotensin‐aldosterone system contributes to hepatic inflammation in metabolic dysfunction‐associated steatotic liver disease (MASLD). Telmisartan, an angiotensin II receptor blocker with partial PPAR‐γ agonistic activity, has been hypothesized to confer metabolic benefits; however, current clinical evidence has not consistently demonstrated such effects. Aim: This systematic review and meta‐analysis evaluated the efficacy of telmisartan on metabolic, biochemical, and histological outcomes in MASLD. Methods: Electronic databases (PubMed, Embase, Web of Science, Scopus) were searched through 2026 for randomized controlled trials (RCTs) investigating telmisartan in adults with MASLD. Risk of bias was assessed using the RoB2 tool. Random‐effects meta‐analyses calculated pooled mean differences (MDs) with 95% confidence intervals (CIs). Results: Six RCTs comprising 258 participants (126 telmisartan, 132 controls) met the inclusion criteria. Telmisartan treatment was associated with a modest reduction in fasting blood sugar compared with controls (MD = −2.78 mg/dL; 95% CI −5.17 to −0.39; p = 0.023); however, this finding was accompanied by substantial heterogeneity (I 2 = 91.8%) and should therefore be interpreted cautiously. No significant changes were observed for body mass index, waist circumference, HOMA‐IR, lipid profiles, ALT, or AST. Conversely, gamma‐glutamyl transferase (GGT) levels showed a modest but significant increase with telmisartan (MD = 5.40 U/L; 95% CI 0.51 to 10.29; p = 0.031). Histological analyses revealed a non‐significant trend toward fibrosis stage improvement (MD = −0.28; 95% CI −0.57 to 0.01; p = 0.060), with no significant improvements seen in the overall NAFLD activity score, steatosis, ballooning, or lobular inflammation. Most included trials carried a low overall risk of bias. Conclusion: Current evidence does not demonstrate consistent metabolic, biochemical, or histological benefits of telmisartan in MASLD. Although a modest reduction in fasting blood glucose was observed, substantial between‐study heterogeneity and the modest effect size limit confidence in this finding.
- Open Access
- 30 July 2026
- Published by Springer Nature in Journal of Rare Diseases
- Vol. 5 (1) , 79
Primary epidermal inclusion cyst of the anterior mediastinum mimicking a thymic cyst: a rare diagnostic pitfall
Background: Epidermal inclusion cysts (EICs) are common benign cutaneous lesions; however, their occurrence in the mediastinum is exceedingly rare. Case presentation: We report a 29-year-old woman with a well-circumscribed mediastinal mass detected on imaging. The lesion was excised via video-assisted thoracoscopic surgery. Gross examination revealed a 6 × 5 × 3 cm cystic mass filled with whitish keratinous material. Histopathologic analysis demonstrated a cyst lined by stratified squamous epithelium with a well-developed granular layer and abundant laminated keratin debris. No adnexal structures or cytologic atypia were identified. Conclusion: Primary mediastinal EIC is a rare benign entity that may radiologically simulate other mediastinal cysts. Accurate diagnosis relies on histopathologic evaluation, and complete excision is curative. Awareness of this entity is important to prevent overdiagnosis and ensure appropriate surgical management. This case emphasizes the importance of considering epidermal inclusion cyst in the differential diagnosis of anterior mediastinal cystic lesions to avoid misdiagnosis and unnecessary aggressive management.
- 30 July 2026
- Published by Springer Nature in Journal of Rare Diseases
- Vol. 5 (1) , 79
Open AccessPrimary epidermal inclusion cyst of the anterior mediastinum mimicking a thymic cyst: a rare diagnostic pitfall
Background: Epidermal inclusion cysts (EICs) are common benign cutaneous lesions; however, their occurrence in the mediastinum is exceedingly rare. Case presentation: We report a 29-year-old woman with a well-circumscribed mediastinal mass detected on imaging. The lesion was excised via video-assisted thoracoscopic surgery. Gross examination revealed a 6 × 5 × 3 cm cystic mass filled with whitish keratinous material. Histopathologic analysis demonstrated a cyst lined by stratified squamous epithelium with a well-developed granular layer and abundant laminated keratin debris. No adnexal structures or cytologic atypia were identified. Conclusion: Primary mediastinal EIC is a rare benign entity that may radiologically simulate other mediastinal cysts. Accurate diagnosis relies on histopathologic evaluation, and complete excision is curative. Awareness of this entity is important to prevent overdiagnosis and ensure appropriate surgical management. This case emphasizes the importance of considering epidermal inclusion cyst in the differential diagnosis of anterior mediastinal cystic lesions to avoid misdiagnosis and unnecessary aggressive management.
- Open Access
- 16 July 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Aorta-sparing total arterial redo-CABG using a recycled patent LIMA: a consecutive 24-patient series with midterm clinical and computed tomographic outcomes
Background: Redo coronary artery bypass grafting (Redo-CABG) poses significant challenges due to complex coronary anatomy and limited conduit availability. In patients with a previously patent left internal mammary artery (LIMA), reusing it as an inflow source for total arterial revascularization (TAR) may offer a durable, stroke-sparing strategy. This study evaluated the safety and midterm outcomes of reusing a patent LIMA as an inflow source in Redo-CABG. Methods: This retrospective case series included 24 patients who underwent Redo-CABG at Faghihi and Dena Hospitals (Shiraz University of Medical Sciences) between March 2015 and October 2023. Consecutive patients were included to minimize selection bias. All patients had a patent LIMA confirmed by angiography or computed tomography angiography (CTA). Arterial grafts (right internal mammary and/or radial artery) were anastomosed to the patent LIMA to achieve complete TAR. Outcomes included perioperative complications, graft patency on CTA, and midterm major adverse cardiac or cerebrovascular events (MACCE). Results: All patients achieved complete TAR with no hospital or 30-day mortality. One patient required reoperation for bleeding. Mean postoperative ejection fraction was 44.5 ± 4.6%, and mean ICU stay was 3.1 ± 0.9 days. Early postoperative CT angiography (at 3 months) and midterm follow-up imaging (median 3.5 years; completed in a subgroup of 12 patients) demonstrated complete graft patency in all evaluated conduits, with no recorded MACCE. Conclusions: Reusing a patent LIMA as an inflow source for total arterial grafting in Redo-CABG appears to be a feasible and safe alternative for high-risk patients with limited conduit options. This approach minimizes extensive aortic manipulation, potentially offering a theoretical advantage in minimizing neurological risks. However, the retrospective, single-center design and small sample size preclude definitive conclusions regarding superiority, warranting further comparative evaluation in larger multicenter studies.
- 16 July 2026
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 21 (1)
Open AccessAorta-sparing total arterial redo-CABG using a recycled patent LIMA: a consecutive 24-patient series with midterm clinical and computed tomographic outcomes
Background: Redo coronary artery bypass grafting (Redo-CABG) poses significant challenges due to complex coronary anatomy and limited conduit availability. In patients with a previously patent left internal mammary artery (LIMA), reusing it as an inflow source for total arterial revascularization (TAR) may offer a durable, stroke-sparing strategy. This study evaluated the safety and midterm outcomes of reusing a patent LIMA as an inflow source in Redo-CABG. Methods: This retrospective case series included 24 patients who underwent Redo-CABG at Faghihi and Dena Hospitals (Shiraz University of Medical Sciences) between March 2015 and October 2023. Consecutive patients were included to minimize selection bias. All patients had a patent LIMA confirmed by angiography or computed tomography angiography (CTA). Arterial grafts (right internal mammary and/or radial artery) were anastomosed to the patent LIMA to achieve complete TAR. Outcomes included perioperative complications, graft patency on CTA, and midterm major adverse cardiac or cerebrovascular events (MACCE). Results: All patients achieved complete TAR with no hospital or 30-day mortality. One patient required reoperation for bleeding. Mean postoperative ejection fraction was 44.5 ± 4.6%, and mean ICU stay was 3.1 ± 0.9 days. Early postoperative CT angiography (at 3 months) and midterm follow-up imaging (median 3.5 years; completed in a subgroup of 12 patients) demonstrated complete graft patency in all evaluated conduits, with no recorded MACCE. Conclusions: Reusing a patent LIMA as an inflow source for total arterial grafting in Redo-CABG appears to be a feasible and safe alternative for high-risk patients with limited conduit options. This approach minimizes extensive aortic manipulation, potentially offering a theoretical advantage in minimizing neurological risks. However, the retrospective, single-center design and small sample size preclude definitive conclusions regarding superiority, warranting further comparative evaluation in larger multicenter studies.
- Open Access
- 9 July 2026
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
Multidisciplinary Decision-Making for Acute Ascending Aortic Dissection Type A in a 31-Week Pregnant Woman
- 9 July 2026
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
Open AccessMultidisciplinary Decision-Making for Acute Ascending Aortic Dissection Type A in a 31-Week Pregnant Woman
- Open Access
- 1 June 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (6) , ytag381
Trauma-triggered coronary embolism causing extensive anterolateral ST-segment elevation myocardial infarction in a young man with a mechanical aortic valve: a case report
Background: Coronary embolism is a rare but clinically important non-atherosclerotic cause of acute myocardial infarction. Its diagnosis becomes especially challenging in young patients with mechanical valves, especially when the presentation follows blunt chest trauma. Case summary: A 24-year-old man with a mechanical aortic valve presented with progressive chest pain and dyspnoea 2 days after blunt chest trauma. Electrocardiography (ECG) demonstrated extensive anterior–lateral ST-segment elevation myocardial infarction (STEMI). Transoesophageal echocardiography revealed normal prosthetic valve function, an apical aneurysm, and a non-mobile left ventricular (LV) mural thrombus. Coronary angiography showed a large thrombotic occlusion in the proximal left anterior descending (LAD) artery with otherwise normal coronary anatomy. Findings were most consistent with coronary embolism originating from a trauma-induced LV mural thrombus. Given the high thrombus burden, the patient received dual antiplatelet therapy, continued warfarin, and tirofiban infusion. Follow-up imaging confirmed complete resolution of the thrombus and improvement in ventricular function. Discussion: This case illustrates the rare mechanism of trauma-induced LV mural thrombus embolization causing STEMI in a young prosthetic-valve patient. Integration of multimodality imaging coupled with meticulous clinical reasoning is required for systematic exclusion of spontaneous coronary artery dissection (SCAD), infective endocarditis, prosthetic-valve thrombosis, hypercoagulable states, and in situ coronary thrombosis to establish the true aetiology. Tirofiban may be an effective adjunct in high-burden embolic coronary occlusions when distal flow is preserved.
- 1 June 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (6) , ytag381
Open AccessTrauma-triggered coronary embolism causing extensive anterolateral ST-segment elevation myocardial infarction in a young man with a mechanical aortic valve: a case report
Background: Coronary embolism is a rare but clinically important non-atherosclerotic cause of acute myocardial infarction. Its diagnosis becomes especially challenging in young patients with mechanical valves, especially when the presentation follows blunt chest trauma. Case summary: A 24-year-old man with a mechanical aortic valve presented with progressive chest pain and dyspnoea 2 days after blunt chest trauma. Electrocardiography (ECG) demonstrated extensive anterior–lateral ST-segment elevation myocardial infarction (STEMI). Transoesophageal echocardiography revealed normal prosthetic valve function, an apical aneurysm, and a non-mobile left ventricular (LV) mural thrombus. Coronary angiography showed a large thrombotic occlusion in the proximal left anterior descending (LAD) artery with otherwise normal coronary anatomy. Findings were most consistent with coronary embolism originating from a trauma-induced LV mural thrombus. Given the high thrombus burden, the patient received dual antiplatelet therapy, continued warfarin, and tirofiban infusion. Follow-up imaging confirmed complete resolution of the thrombus and improvement in ventricular function. Discussion: This case illustrates the rare mechanism of trauma-induced LV mural thrombus embolization causing STEMI in a young prosthetic-valve patient. Integration of multimodality imaging coupled with meticulous clinical reasoning is required for systematic exclusion of spontaneous coronary artery dissection (SCAD), infective endocarditis, prosthetic-valve thrombosis, hypercoagulable states, and in situ coronary thrombosis to establish the true aetiology. Tirofiban may be an effective adjunct in high-burden embolic coronary occlusions when distal flow is preserved.
- Open Access
- 27 November 2025
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 19 (1) , 620
From sting to pacemaker: a case of complete heart block following yellow scorpion envenomation—a case report
Scorpion envenomation is a significant medical concern in tropical and subtropical regions, with cardiovascular complications being among its most severe m
- 27 November 2025
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 19 (1) , 620
Open AccessFrom sting to pacemaker: a case of complete heart block following yellow scorpion envenomation—a case report
Scorpion envenomation is a significant medical concern in tropical and subtropical regions, with cardiovascular complications being among its most severe m
- Open Access
- 9 July 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (7) , e71026
Association Between ECG Findings and Atherosclerotic Cardiovascular Disease (ASCVD) Risk Score: A Cross‐Sectional Analysis of a Cohort Study
Background and Aims: Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, making early detection and risk assessment critical. Various clinical tools, including the Atherosclerotic Cardiovascular Disease (ASCVD) risk score, have been developed to predict cardiovascular risk. This study aimed to evaluate the association of various Electrocardiogram (ECG) findings with 10‐year ASCVD risk scores in asymptomatic individuals without prior cardiovascular events, using data from the Shiraz Heart Study (SHS). Materials and Methods: This cross‐sectional study included participants aged 40–70 years from the Shiraz Heart Study (SHS). Inclusion criteria required complete ECG data and recorded ASCVD risk factors. ECG findings, encompassing both continuous and categorical variables, were reviewed by trained cardiologists. ASCVD risk scores were calculated using demographic and clinical variables. Statistical analyses, including multivariate regression, assessed associations between ECG parameters and 10‐year ASCVD risk scores, adjusting for key confounders. Result: A total of 1471 participants were included in the study, with 44.5% male ( N = 654) and a mean age of 51.65 years (SD = 7.84). The mean ASCVD score was 5.49 (SD = 6.41). Significant associations were found between continuous ECG variables, such as P‐wave duration, PR interval, QRS duration, and QRS axis, with ASCVD risk. Categorical ECG findings, including ST depression, ST elevation, left bundle branch block (LBBB), prolonged P‐wave duration, and left atrial enlargement, were also significantly associated with ASCVD scores. Multivariate linear regression identified ST depression ( B = 0.060, p < 0.001) and LBBB ( B = 0.031, p = 0.039) as independent predictors of ASCVD risk, after adjusting for confounders such as age, gender, hypertension, diabetes, and cholesterol levels. Conclusion: ST depression and LBBB show a modest association with cardiovascular risk stratification using the 10‐year ASCVD risk score. Incorporating these ECG markers into clinical assessments may aid in identifying high‐risk individuals, enabling more personalized interventions and refining cardiovascular risk prediction models.
- 9 July 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (7) , e71026
Open AccessAssociation Between ECG Findings and Atherosclerotic Cardiovascular Disease (ASCVD) Risk Score: A Cross‐Sectional Analysis of a Cohort Study
Background and Aims: Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, making early detection and risk assessment critical. Various clinical tools, including the Atherosclerotic Cardiovascular Disease (ASCVD) risk score, have been developed to predict cardiovascular risk. This study aimed to evaluate the association of various Electrocardiogram (ECG) findings with 10‐year ASCVD risk scores in asymptomatic individuals without prior cardiovascular events, using data from the Shiraz Heart Study (SHS). Materials and Methods: This cross‐sectional study included participants aged 40–70 years from the Shiraz Heart Study (SHS). Inclusion criteria required complete ECG data and recorded ASCVD risk factors. ECG findings, encompassing both continuous and categorical variables, were reviewed by trained cardiologists. ASCVD risk scores were calculated using demographic and clinical variables. Statistical analyses, including multivariate regression, assessed associations between ECG parameters and 10‐year ASCVD risk scores, adjusting for key confounders. Result: A total of 1471 participants were included in the study, with 44.5% male ( N = 654) and a mean age of 51.65 years (SD = 7.84). The mean ASCVD score was 5.49 (SD = 6.41). Significant associations were found between continuous ECG variables, such as P‐wave duration, PR interval, QRS duration, and QRS axis, with ASCVD risk. Categorical ECG findings, including ST depression, ST elevation, left bundle branch block (LBBB), prolonged P‐wave duration, and left atrial enlargement, were also significantly associated with ASCVD scores. Multivariate linear regression identified ST depression ( B = 0.060, p < 0.001) and LBBB ( B = 0.031, p = 0.039) as independent predictors of ASCVD risk, after adjusting for confounders such as age, gender, hypertension, diabetes, and cholesterol levels. Conclusion: ST depression and LBBB show a modest association with cardiovascular risk stratification using the 10‐year ASCVD risk score. Incorporating these ECG markers into clinical assessments may aid in identifying high‐risk individuals, enabling more personalized interventions and refining cardiovascular risk prediction models.
- Open Access
- 8 November 2024
- Published by Wiley
The Uncommon ECG Signature of Hypokalemia: Left Main Coronary Equivalent
- 8 November 2024
- Published by Wiley
Open AccessThe Uncommon ECG Signature of Hypokalemia: Left Main Coronary Equivalent